N
Natera Inc (NTRA)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
$288.48
-30.61 (-9.59%)
Market Cap: $46.27B
Last updated: Nov 17, 2026 at 11:06 AM ET
Natera Inc (NTRA) Valuation Multiples
Natera (NTRA) trades at 14.3x sales and 22.2x book value. Its P/S of 14.3x is above its 5-year median of 9.6x.
Current Multiples
Its free cash flow yield is 0.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 14.3x |
| Price to book | 22.2x |
| Price to FCF | 792.1x |
| EV/FCF | 773.6x |
| PEG | N/A |
| FCF yield | 0.1% |
Historical Medians
Against its 10-year medians, its P/S is 81.0% above 7.9x and its P/B is 39.6% above 15.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 14.3x | 9.6x | 7.9x |
| P/B | 22.2x | 14.4x | 15.9x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 2.3x in 2017 to 20.3x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $229.09 | 13.5x | 18.3x |
| 2024 | $158.30 | 11.5x | 16.5x |
| 2023 | $62.64 | 6.7x | 9.8x |
| 2022 | $40.17 | 4.7x | 5.6x |
| 2021 | $93.39 | 13.4x | 13.2x |
| 2020 | $99.52 | 20.3x | 16.6x |
| 2019 | $33.69 | 7.8x | 9.5x |
| 2018 | $13.96 | 3.1x | 27.3x |
| 2017 | $8.99 | 2.3x | 19.1x |
| 2016 | $11.71 | 2.8x | 5.8x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NTRA
Is NTRA stock overvalued?
GNG's valuation label for NTRA is Fairly valued.
What is NTRA's price to sales ratio?
Natera has a price to sales ratio of 14.3x.
NTRA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts